Global Plasma-derived Medicinal Products Supply, Demand and Key Producers, 2023-2029

Description

The global Plasma-derived Medicinal Products market size is expected to reach $ 47640 million by 2029, rising at a market growth of 7.3% CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Plasma-derived medicinal products (PDMPs) are industrially manufactured from human plasma by pharmaceutical companies. Plasma is the liquid part of blood and it can be collected through specific procedures called plasmapheresis or obtained by the separation from the other components through physical means (centrifugation). PDMPs play a key, and sometimes non-replaceable, role in the treatment of many acute and chronic clinical conditions.

This report studies the global Plasma-derived Medicinal Products production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Plasma-derived Medicinal Products, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Plasma-derived Medicinal Products that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Plasma-derived Medicinal Products total production and demand, 2018-2029, (K Units)
Global Plasma-derived Medicinal Products total production value, 2018-2029, (USD Million)
Global Plasma-derived Medicinal Products production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Plasma-derived Medicinal Products consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Plasma-derived Medicinal Products domestic production, consumption, key domestic manufacturers and share
Global Plasma-derived Medicinal Products production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Plasma-derived Medicinal Products production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Plasma-derived Medicinal Products production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Plasma-derived Medicinal Products market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and Shanghai RAAS, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Plasma-derived Medicinal Products market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Plasma-derived Medicinal Products Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Plasma-derived Medicinal Products Market, Segmentation by Type
    Immunoglobulins
    Coagulation Factor Concentrates
    Other

Global Plasma-derived Medicinal Products Market, Segmentation by Application
    Emergency Care
    Epidemic Diseasae
    Immune System Disorder
    Antibody Deficiency
    Coagulation Disorder
    Others

Companies Profiled:
    Takeda
    CSL
    Grifols
    Octapharma
    Kedrion
    LFB Group
    Biotest
    BPL
    Shanghai RAAS
    China Biologic Products
    Hualan Biological Engineering Inc.
    Beijing Tiantan Biological Products Corp
    Pacific Shuanglin
    Boya Bio-Pharmaceutical
    Paisi Feike Biology Pharmacy Co., Ltd.
    Xinjiang Deyuan Bioengineering
    Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
    Shenzhen Weiguang
    Shanxi Kangbao
    Nanyue Biopharming Corporation Ltd

Key Questions Answered
1. How big is the global Plasma-derived Medicinal Products market?
2. What is the demand of the global Plasma-derived Medicinal Products market?
3. What is the year over year growth of the global Plasma-derived Medicinal Products market?
4. What is the production and production value of the global Plasma-derived Medicinal Products market?
5. Who are the key producers in the global Plasma-derived Medicinal Products market?

Table of Contents

1 Supply Summary
    1.1 Plasma-derived Medicinal Products Introduction
    1.2 World Plasma-derived Medicinal Products Supply & Forecast
        1.2.1 World Plasma-derived Medicinal Products Production Value (2018 & 2022 & 2029)
        1.2.2 World Plasma-derived Medicinal Products Production (2018-2029)
        1.2.3 World Plasma-derived Medicinal Products Pricing Trends (2018-2029)
    1.3 World Plasma-derived Medicinal Products Production by Region (Based on Production Site)
        1.3.1 World Plasma-derived Medicinal Products Production Value by Region (2018-2029)
        1.3.2 World Plasma-derived Medicinal Products Production by Region (2018-2029)
        1.3.3 World Plasma-derived Medicinal Products Average Price by Region (2018-2029)
        1.3.4 North America Plasma-derived Medicinal Products Production (2018-2029)
        1.3.5 Europe Plasma-derived Medicinal Products Production (2018-2029)
        1.3.6 China Plasma-derived Medicinal Products Production (2018-2029)
        1.3.7 Japan Plasma-derived Medicinal Products Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Plasma-derived Medicinal Products Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Plasma-derived Medicinal Products Major Market Trends

2 Demand Summary
    2.1 World Plasma-derived Medicinal Products Demand (2018-2029)
    2.2 World Plasma-derived Medicinal Products Consumption by Region
        2.2.1 World Plasma-derived Medicinal Products Consumption by Region (2018-2023)
        2.2.2 World Plasma-derived Medicinal Products Consumption Forecast by Region (2024-2029)
    2.3 United States Plasma-derived Medicinal Products Consumption (2018-2029)
    2.4 China Plasma-derived Medicinal Products Consumption (2018-2029)
    2.5 Europe Plasma-derived Medicinal Products Consumption (2018-2029)
    2.6 Japan Plasma-derived Medicinal Products Consumption (2018-2029)
    2.7 South Korea Plasma-derived Medicinal Products Consumption (2018-2029)
    2.8 ASEAN Plasma-derived Medicinal Products Consumption (2018-2029)
    2.9 India Plasma-derived Medicinal Products Consumption (2018-2029)

3 World Plasma-derived Medicinal Products Manufacturers Competitive Analysis
    3.1 World Plasma-derived Medicinal Products Production Value by Manufacturer (2018-2023)
    3.2 World Plasma-derived Medicinal Products Production by Manufacturer (2018-2023)
    3.3 World Plasma-derived Medicinal Products Average Price by Manufacturer (2018-2023)
    3.4 Plasma-derived Medicinal Products Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Plasma-derived Medicinal Products Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Plasma-derived Medicinal Products in 2022
        3.5.3 Global Concentration Ratios (CR8) for Plasma-derived Medicinal Products in 2022
    3.6 Plasma-derived Medicinal Products Market: Overall Company Footprint Analysis
        3.6.1 Plasma-derived Medicinal Products Market: Region Footprint
        3.6.2 Plasma-derived Medicinal Products Market: Company Product Type Footprint
        3.6.3 Plasma-derived Medicinal Products Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Plasma-derived Medicinal Products Production Value Comparison
        4.1.1 United States VS China: Plasma-derived Medicinal Products Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Plasma-derived Medicinal Products Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Plasma-derived Medicinal Products Production Comparison
        4.2.1 United States VS China: Plasma-derived Medicinal Products Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Plasma-derived Medicinal Products Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Plasma-derived Medicinal Products Consumption Comparison
        4.3.1 United States VS China: Plasma-derived Medicinal Products Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Plasma-derived Medicinal Products Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Plasma-derived Medicinal Products Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Plasma-derived Medicinal Products Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Plasma-derived Medicinal Products Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Plasma-derived Medicinal Products Production (2018-2023)
    4.5 China Based Plasma-derived Medicinal Products Manufacturers and Market Share
        4.5.1 China Based Plasma-derived Medicinal Products Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Plasma-derived Medicinal Products Production Value (2018-2023)
        4.5.3 China Based Manufacturers Plasma-derived Medicinal Products Production (2018-2023)
    4.6 Rest of World Based Plasma-derived Medicinal Products Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Plasma-derived Medicinal Products Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Plasma-derived Medicinal Products Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Plasma-derived Medicinal Products Production (2018-2023)

5 Market Analysis by Type
    5.1 World Plasma-derived Medicinal Products Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Immunoglobulins
        5.2.2 Coagulation Factor Concentrates
        5.2.3 Other
    5.3 Market Segment by Type
        5.3.1 World Plasma-derived Medicinal Products Production by Type (2018-2029)
        5.3.2 World Plasma-derived Medicinal Products Production Value by Type (2018-2029)
        5.3.3 World Plasma-derived Medicinal Products Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Plasma-derived Medicinal Products Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Emergency Care
        6.2.2 Epidemic Diseasae
        6.2.3 Immune System Disorder
        6.2.4 Antibody Deficiency
        6.2.5 Coagulation Disorder
        6.2.6 Others
    6.3 Market Segment by Application
        6.3.1 World Plasma-derived Medicinal Products Production by Application (2018-2029)
        6.3.2 World Plasma-derived Medicinal Products Production Value by Application (2018-2029)
        6.3.3 World Plasma-derived Medicinal Products Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Takeda
        7.1.1 Takeda Details
        7.1.2 Takeda Major Business
        7.1.3 Takeda Plasma-derived Medicinal Products Product and Services
        7.1.4 Takeda Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Takeda Recent Developments/Updates
        7.1.6 Takeda Competitive Strengths & Weaknesses
    7.2 CSL
        7.2.1 CSL Details
        7.2.2 CSL Major Business
        7.2.3 CSL Plasma-derived Medicinal Products Product and Services
        7.2.4 CSL Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 CSL Recent Developments/Updates
        7.2.6 CSL Competitive Strengths & Weaknesses
    7.3 Grifols
        7.3.1 Grifols Details
        7.3.2 Grifols Major Business
        7.3.3 Grifols Plasma-derived Medicinal Products Product and Services
        7.3.4 Grifols Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Grifols Recent Developments/Updates
        7.3.6 Grifols Competitive Strengths & Weaknesses
    7.4 Octapharma
        7.4.1 Octapharma Details
        7.4.2 Octapharma Major Business
        7.4.3 Octapharma Plasma-derived Medicinal Products Product and Services
        7.4.4 Octapharma Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Octapharma Recent Developments/Updates
        7.4.6 Octapharma Competitive Strengths & Weaknesses
    7.5 Kedrion
        7.5.1 Kedrion Details
        7.5.2 Kedrion Major Business
        7.5.3 Kedrion Plasma-derived Medicinal Products Product and Services
        7.5.4 Kedrion Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Kedrion Recent Developments/Updates
        7.5.6 Kedrion Competitive Strengths & Weaknesses
    7.6 LFB Group
        7.6.1 LFB Group Details
        7.6.2 LFB Group Major Business
        7.6.3 LFB Group Plasma-derived Medicinal Products Product and Services
        7.6.4 LFB Group Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 LFB Group Recent Developments/Updates
        7.6.6 LFB Group Competitive Strengths & Weaknesses
    7.7 Biotest
        7.7.1 Biotest Details
        7.7.2 Biotest Major Business
        7.7.3 Biotest Plasma-derived Medicinal Products Product and Services
        7.7.4 Biotest Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Biotest Recent Developments/Updates
        7.7.6 Biotest Competitive Strengths & Weaknesses
    7.8 BPL
        7.8.1 BPL Details
        7.8.2 BPL Major Business
        7.8.3 BPL Plasma-derived Medicinal Products Product and Services
        7.8.4 BPL Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 BPL Recent Developments/Updates
        7.8.6 BPL Competitive Strengths & Weaknesses
    7.9 Shanghai RAAS
        7.9.1 Shanghai RAAS Details
        7.9.2 Shanghai RAAS Major Business
        7.9.3 Shanghai RAAS Plasma-derived Medicinal Products Product and Services
        7.9.4 Shanghai RAAS Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Shanghai RAAS Recent Developments/Updates
        7.9.6 Shanghai RAAS Competitive Strengths & Weaknesses
    7.10 China Biologic Products
        7.10.1 China Biologic Products Details
        7.10.2 China Biologic Products Major Business
        7.10.3 China Biologic Products Plasma-derived Medicinal Products Product and Services
        7.10.4 China Biologic Products Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 China Biologic Products Recent Developments/Updates
        7.10.6 China Biologic Products Competitive Strengths & Weaknesses
    7.11 Hualan Biological Engineering Inc.
        7.11.1 Hualan Biological Engineering Inc. Details
        7.11.2 Hualan Biological Engineering Inc. Major Business
        7.11.3 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product and Services
        7.11.4 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Hualan Biological Engineering Inc. Recent Developments/Updates
        7.11.6 Hualan Biological Engineering Inc. Competitive Strengths & Weaknesses
    7.12 Beijing Tiantan Biological Products Corp
        7.12.1 Beijing Tiantan Biological Products Corp Details
        7.12.2 Beijing Tiantan Biological Products Corp Major Business
        7.12.3 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product and Services
        7.12.4 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Beijing Tiantan Biological Products Corp Recent Developments/Updates
        7.12.6 Beijing Tiantan Biological Products Corp Competitive Strengths & Weaknesses
    7.13 Pacific Shuanglin
        7.13.1 Pacific Shuanglin Details
        7.13.2 Pacific Shuanglin Major Business
        7.13.3 Pacific Shuanglin Plasma-derived Medicinal Products Product and Services
        7.13.4 Pacific Shuanglin Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Pacific Shuanglin Recent Developments/Updates
        7.13.6 Pacific Shuanglin Competitive Strengths & Weaknesses
    7.14 Boya Bio-Pharmaceutical
        7.14.1 Boya Bio-Pharmaceutical Details
        7.14.2 Boya Bio-Pharmaceutical Major Business
        7.14.3 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product and Services
        7.14.4 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Boya Bio-Pharmaceutical Recent Developments/Updates
        7.14.6 Boya Bio-Pharmaceutical Competitive Strengths & Weaknesses
    7.15 Paisi Feike Biology Pharmacy Co., Ltd.
        7.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Details
        7.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Major Business
        7.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Product and Services
        7.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments/Updates
        7.15.6 Paisi Feike Biology Pharmacy Co., Ltd. Competitive Strengths & Weaknesses
    7.16 Xinjiang Deyuan Bioengineering
        7.16.1 Xinjiang Deyuan Bioengineering Details
        7.16.2 Xinjiang Deyuan Bioengineering Major Business
        7.16.3 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product and Services
        7.16.4 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Xinjiang Deyuan Bioengineering Recent Developments/Updates
        7.16.6 Xinjiang Deyuan Bioengineering Competitive Strengths & Weaknesses
    7.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
        7.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Details
        7.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Major Business
        7.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Product and Services
        7.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments/Updates
        7.17.6 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
    7.18 Shenzhen Weiguang
        7.18.1 Shenzhen Weiguang Details
        7.18.2 Shenzhen Weiguang Major Business
        7.18.3 Shenzhen Weiguang Plasma-derived Medicinal Products Product and Services
        7.18.4 Shenzhen Weiguang Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.18.5 Shenzhen Weiguang Recent Developments/Updates
        7.18.6 Shenzhen Weiguang Competitive Strengths & Weaknesses
    7.19 Shanxi Kangbao
        7.19.1 Shanxi Kangbao Details
        7.19.2 Shanxi Kangbao Major Business
        7.19.3 Shanxi Kangbao Plasma-derived Medicinal Products Product and Services
        7.19.4 Shanxi Kangbao Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.19.5 Shanxi Kangbao Recent Developments/Updates
        7.19.6 Shanxi Kangbao Competitive Strengths & Weaknesses
    7.20 Nanyue Biopharming Corporation Ltd
        7.20.1 Nanyue Biopharming Corporation Ltd Details
        7.20.2 Nanyue Biopharming Corporation Ltd Major Business
        7.20.3 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product and Services
        7.20.4 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.20.5 Nanyue Biopharming Corporation Ltd Recent Developments/Updates
        7.20.6 Nanyue Biopharming Corporation Ltd Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Plasma-derived Medicinal Products Industry Chain
    8.2 Plasma-derived Medicinal Products Upstream Analysis
        8.2.1 Plasma-derived Medicinal Products Core Raw Materials
        8.2.2 Main Manufacturers of Plasma-derived Medicinal Products Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Plasma-derived Medicinal Products Production Mode
    8.6 Plasma-derived Medicinal Products Procurement Model
    8.7 Plasma-derived Medicinal Products Industry Sales Model and Sales Channels
        8.7.1 Plasma-derived Medicinal Products Sales Model
        8.7.2 Plasma-derived Medicinal Products Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Plasma-derived Medicinal Products Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Plasma-derived Medicinal Products Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Plasma-derived Medicinal Products Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Plasma-derived Medicinal Products Production Value Market Share by Region (2018-2023)
    Table 5. World Plasma-derived Medicinal Products Production Value Market Share by Region (2024-2029)
    Table 6. World Plasma-derived Medicinal Products Production by Region (2018-2023) & (K Units)
    Table 7. World Plasma-derived Medicinal Products Production by Region (2024-2029) & (K Units)
    Table 8. World Plasma-derived Medicinal Products Production Market Share by Region (2018-2023)
    Table 9. World Plasma-derived Medicinal Products Production Market Share by Region (2024-2029)
    Table 10. World Plasma-derived Medicinal Products Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Plasma-derived Medicinal Products Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Plasma-derived Medicinal Products Major Market Trends
    Table 13. World Plasma-derived Medicinal Products Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Plasma-derived Medicinal Products Consumption by Region (2018-2023) & (K Units)
    Table 15. World Plasma-derived Medicinal Products Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Plasma-derived Medicinal Products Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Plasma-derived Medicinal Products Producers in 2022
    Table 18. World Plasma-derived Medicinal Products Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Plasma-derived Medicinal Products Producers in 2022
    Table 20. World Plasma-derived Medicinal Products Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Plasma-derived Medicinal Products Company Evaluation Quadrant
    Table 22. World Plasma-derived Medicinal Products Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Plasma-derived Medicinal Products Production Site of Key Manufacturer
    Table 24. Plasma-derived Medicinal Products Market: Company Product Type Footprint
    Table 25. Plasma-derived Medicinal Products Market: Company Product Application Footprint
    Table 26. Plasma-derived Medicinal Products Competitive Factors
    Table 27. Plasma-derived Medicinal Products New Entrant and Capacity Expansion Plans
    Table 28. Plasma-derived Medicinal Products Mergers & Acquisitions Activity
    Table 29. United States VS China Plasma-derived Medicinal Products Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Plasma-derived Medicinal Products Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Plasma-derived Medicinal Products Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Plasma-derived Medicinal Products Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Plasma-derived Medicinal Products Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Plasma-derived Medicinal Products Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Plasma-derived Medicinal Products Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Plasma-derived Medicinal Products Production Market Share (2018-2023)
    Table 37. China Based Plasma-derived Medicinal Products Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Plasma-derived Medicinal Products Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Plasma-derived Medicinal Products Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Plasma-derived Medicinal Products Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Plasma-derived Medicinal Products Production Market Share (2018-2023)
    Table 42. Rest of World Based Plasma-derived Medicinal Products Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Plasma-derived Medicinal Products Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Plasma-derived Medicinal Products Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Plasma-derived Medicinal Products Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Plasma-derived Medicinal Products Production Market Share (2018-2023)
    Table 47. World Plasma-derived Medicinal Products Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Plasma-derived Medicinal Products Production by Type (2018-2023) & (K Units)
    Table 49. World Plasma-derived Medicinal Products Production by Type (2024-2029) & (K Units)
    Table 50. World Plasma-derived Medicinal Products Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Plasma-derived Medicinal Products Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Plasma-derived Medicinal Products Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Plasma-derived Medicinal Products Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Plasma-derived Medicinal Products Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Plasma-derived Medicinal Products Production by Application (2018-2023) & (K Units)
    Table 56. World Plasma-derived Medicinal Products Production by Application (2024-2029) & (K Units)
    Table 57. World Plasma-derived Medicinal Products Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Plasma-derived Medicinal Products Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Plasma-derived Medicinal Products Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Plasma-derived Medicinal Products Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Takeda Basic Information, Manufacturing Base and Competitors
    Table 62. Takeda Major Business
    Table 63. Takeda Plasma-derived Medicinal Products Product and Services
    Table 64. Takeda Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Takeda Recent Developments/Updates
    Table 66. Takeda Competitive Strengths & Weaknesses
    Table 67. CSL Basic Information, Manufacturing Base and Competitors
    Table 68. CSL Major Business
    Table 69. CSL Plasma-derived Medicinal Products Product and Services
    Table 70. CSL Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. CSL Recent Developments/Updates
    Table 72. CSL Competitive Strengths & Weaknesses
    Table 73. Grifols Basic Information, Manufacturing Base and Competitors
    Table 74. Grifols Major Business
    Table 75. Grifols Plasma-derived Medicinal Products Product and Services
    Table 76. Grifols Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Grifols Recent Developments/Updates
    Table 78. Grifols Competitive Strengths & Weaknesses
    Table 79. Octapharma Basic Information, Manufacturing Base and Competitors
    Table 80. Octapharma Major Business
    Table 81. Octapharma Plasma-derived Medicinal Products Product and Services
    Table 82. Octapharma Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Octapharma Recent Developments/Updates
    Table 84. Octapharma Competitive Strengths & Weaknesses
    Table 85. Kedrion Basic Information, Manufacturing Base and Competitors
    Table 86. Kedrion Major Business
    Table 87. Kedrion Plasma-derived Medicinal Products Product and Services
    Table 88. Kedrion Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Kedrion Recent Developments/Updates
    Table 90. Kedrion Competitive Strengths & Weaknesses
    Table 91. LFB Group Basic Information, Manufacturing Base and Competitors
    Table 92. LFB Group Major Business
    Table 93. LFB Group Plasma-derived Medicinal Products Product and Services
    Table 94. LFB Group Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. LFB Group Recent Developments/Updates
    Table 96. LFB Group Competitive Strengths & Weaknesses
    Table 97. Biotest Basic Information, Manufacturing Base and Competitors
    Table 98. Biotest Major Business
    Table 99. Biotest Plasma-derived Medicinal Products Product and Services
    Table 100. Biotest Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Biotest Recent Developments/Updates
    Table 102. Biotest Competitive Strengths & Weaknesses
    Table 103. BPL Basic Information, Manufacturing Base and Competitors
    Table 104. BPL Major Business
    Table 105. BPL Plasma-derived Medicinal Products Product and Services
    Table 106. BPL Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. BPL Recent Developments/Updates
    Table 108. BPL Competitive Strengths & Weaknesses
    Table 109. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
    Table 110. Shanghai RAAS Major Business
    Table 111. Shanghai RAAS Plasma-derived Medicinal Products Product and Services
    Table 112. Shanghai RAAS Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Shanghai RAAS Recent Developments/Updates
    Table 114. Shanghai RAAS Competitive Strengths & Weaknesses
    Table 115. China Biologic Products Basic Information, Manufacturing Base and Competitors
    Table 116. China Biologic Products Major Business
    Table 117. China Biologic Products Plasma-derived Medicinal Products Product and Services
    Table 118. China Biologic Products Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. China Biologic Products Recent Developments/Updates
    Table 120. China Biologic Products Competitive Strengths & Weaknesses
    Table 121. Hualan Biological Engineering Inc. Basic Information, Manufacturing Base and Competitors
    Table 122. Hualan Biological Engineering Inc. Major Business
    Table 123. Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product and Services
    Table 124. Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Hualan Biological Engineering Inc. Recent Developments/Updates
    Table 126. Hualan Biological Engineering Inc. Competitive Strengths & Weaknesses
    Table 127. Beijing Tiantan Biological Products Corp Basic Information, Manufacturing Base and Competitors
    Table 128. Beijing Tiantan Biological Products Corp Major Business
    Table 129. Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product and Services
    Table 130. Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Beijing Tiantan Biological Products Corp Recent Developments/Updates
    Table 132. Beijing Tiantan Biological Products Corp Competitive Strengths & Weaknesses
    Table 133. Pacific Shuanglin Basic Information, Manufacturing Base and Competitors
    Table 134. Pacific Shuanglin Major Business
    Table 135. Pacific Shuanglin Plasma-derived Medicinal Products Product and Services
    Table 136. Pacific Shuanglin Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Pacific Shuanglin Recent Developments/Updates
    Table 138. Pacific Shuanglin Competitive Strengths & Weaknesses
    Table 139. Boya Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 140. Boya Bio-Pharmaceutical Major Business
    Table 141. Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product and Services
    Table 142. Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. Boya Bio-Pharmaceutical Recent Developments/Updates
    Table 144. Boya Bio-Pharmaceutical Competitive Strengths & Weaknesses
    Table 145. Paisi Feike Biology Pharmacy Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 146. Paisi Feike Biology Pharmacy Co., Ltd. Major Business
    Table 147. Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Product and Services
    Table 148. Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments/Updates
    Table 150. Paisi Feike Biology Pharmacy Co., Ltd. Competitive Strengths & Weaknesses
    Table 151. Xinjiang Deyuan Bioengineering Basic Information, Manufacturing Base and Competitors
    Table 152. Xinjiang Deyuan Bioengineering Major Business
    Table 153. Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product and Services
    Table 154. Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 155. Xinjiang Deyuan Bioengineering Recent Developments/Updates
    Table 156. Xinjiang Deyuan Bioengineering Competitive Strengths & Weaknesses
    Table 157. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 158. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Major Business
    Table 159. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Product and Services
    Table 160. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 161. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments/Updates
    Table 162. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
    Table 163. Shenzhen Weiguang Basic Information, Manufacturing Base and Competitors
    Table 164. Shenzhen Weiguang Major Business
    Table 165. Shenzhen Weiguang Plasma-derived Medicinal Products Product and Services
    Table 166. Shenzhen Weiguang Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 167. Shenzhen Weiguang Recent Developments/Updates
    Table 168. Shenzhen Weiguang Competitive Strengths & Weaknesses
    Table 169. Shanxi Kangbao Basic Information, Manufacturing Base and Competitors
    Table 170. Shanxi Kangbao Major Business
    Table 171. Shanxi Kangbao Plasma-derived Medicinal Products Product and Services
    Table 172. Shanxi Kangbao Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 173. Shanxi Kangbao Recent Developments/Updates
    Table 174. Nanyue Biopharming Corporation Ltd Basic Information, Manufacturing Base and Competitors
    Table 175. Nanyue Biopharming Corporation Ltd Major Business
    Table 176. Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product and Services
    Table 177. Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 178. Global Key Players of Plasma-derived Medicinal Products Upstream (Raw Materials)
    Table 179. Plasma-derived Medicinal Products Typical Customers
    Table 180. Plasma-derived Medicinal Products Typical Distributors
List of Figure
    Figure 1. Plasma-derived Medicinal Products Picture
    Figure 2. World Plasma-derived Medicinal Products Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Plasma-derived Medicinal Products Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Plasma-derived Medicinal Products Production (2018-2029) & (K Units)
    Figure 5. World Plasma-derived Medicinal Products Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Plasma-derived Medicinal Products Production Value Market Share by Region (2018-2029)
    Figure 7. World Plasma-derived Medicinal Products Production Market Share by Region (2018-2029)
    Figure 8. North America Plasma-derived Medicinal Products Production (2018-2029) & (K Units)
    Figure 9. Europe Plasma-derived Medicinal Products Production (2018-2029) & (K Units)
    Figure 10. China Plasma-derived Medicinal Products Production (2018-2029) & (K Units)
    Figure 11. Japan Plasma-derived Medicinal Products Production (2018-2029) & (K Units)
    Figure 12. Plasma-derived Medicinal Products Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Plasma-derived Medicinal Products Consumption (2018-2029) & (K Units)
    Figure 15. World Plasma-derived Medicinal Products Consumption Market Share by Region (2018-2029)
    Figure 16. United States Plasma-derived Medicinal Products Consumption (2018-2029) & (K Units)
    Figure 17. China Plasma-derived Medicinal Products Consumption (2018-2029) & (K Units)
    Figure 18. Europe Plasma-derived Medicinal Products Consumption (2018-2029) & (K Units)
    Figure 19. Japan Plasma-derived Medicinal Products Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Plasma-derived Medicinal Products Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Plasma-derived Medicinal Products Consumption (2018-2029) & (K Units)
    Figure 22. India Plasma-derived Medicinal Products Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Plasma-derived Medicinal Products by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Plasma-derived Medicinal Products Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Plasma-derived Medicinal Products Markets in 2022
    Figure 26. United States VS China: Plasma-derived Medicinal Products Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Plasma-derived Medicinal Products Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Plasma-derived Medicinal Products Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Plasma-derived Medicinal Products Production Market Share 2022
    Figure 30. China Based Manufacturers Plasma-derived Medicinal Products Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Plasma-derived Medicinal Products Production Market Share 2022
    Figure 32. World Plasma-derived Medicinal Products Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Plasma-derived Medicinal Products Production Value Market Share by Type in 2022
    Figure 34. Immunoglobulins
    Figure 35. Coagulation Factor Concentrates
    Figure 36. Other
    Figure 37. World Plasma-derived Medicinal Products Production Market Share by Type (2018-2029)
    Figure 38. World Plasma-derived Medicinal Products Production Value Market Share by Type (2018-2029)
    Figure 39. World Plasma-derived Medicinal Products Average Price by Type (2018-2029) & (US$/Unit)
    Figure 40. World Plasma-derived Medicinal Products Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Plasma-derived Medicinal Products Production Value Market Share by Application in 2022
    Figure 42. Emergency Care
    Figure 43. Epidemic Diseasae
    Figure 44. Immune System Disorder
    Figure 45. Antibody Deficiency
    Figure 46. Coagulation Disorder
    Figure 47. Others
    Figure 48. World Plasma-derived Medicinal Products Production Market Share by Application (2018-2029)
    Figure 49. World Plasma-derived Medicinal Products Production Value Market Share by Application (2018-2029)
    Figure 50. World Plasma-derived Medicinal Products Average Price by Application (2018-2029) & (US$/Unit)
    Figure 51. Plasma-derived Medicinal Products Industry Chain
    Figure 52. Plasma-derived Medicinal Products Procurement Model
    Figure 53. Plasma-derived Medicinal Products Sales Model
    Figure 54. Plasma-derived Medicinal Products Sales Channels, Direct Sales, and Distribution
    Figure 55. Methodology
    Figure 56. Research Process and Data Source

Companies Mentioned

Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
Shanghai RAAS
China Biologic Products
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Boya Bio-Pharmaceutical
Paisi Feike Biology Pharmacy Co., Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd